Bibliografía del artículo
1. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 167:141-7, 2007.
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49:69-75, 2007.
3. Banegas JR, Rodríguez Artalejo F. El problema de la hipertensión arterial en España. Rev Clin Esp 202:12-5, 2002.
4. Barrios V, Escobar C, Llisterri JL, Calderon A, Alegria E, Muñiz J, et al. Control de presión arterial y lípidos y riesgo coronario en la población hipertensa asistida en atención primaria en España. Estudio PRESCOT. Rev Clin Esp 2007 (en prensa).
5. Sierra A, Ruilope LM, Coca A, Luque Otero M. Relación entre el riesgo cardiovascular y el tratamiento antihipertensivo. Med Clin 115:41-5, 2000.
6. Barrios V, Escobar C, Calderón A, Echarri R, González Pededl V, Ruilope LM. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens 2007 (en prensa).
7. Steg PG, López Sendon J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA Jr, et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167:68-73, 2007.
8. McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs 60:1123-1140, 2002.
9. Epstein M. Lercanidipine: a novel dihydropyridine calcium-channel blocker. Heart Dis 3:398-407, 2001.
10. Barrios V, Navarro A, Esteras A, Luque M, Romero J, Tamargo J, et al. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Blood Press 11:95-100, 2002.
11. Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A; COHORT Study Group. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens 15:932-940, 2002.
12. Romito R, Pansini MI, Perticone F, Antonelli G, Pitzalis M, Rizzon P. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study. J Clin Hypertens (Greenwich) 5:249-253, 2003.
13. Agrawal R, Marx A, Haller H. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. J Hypertens 24:185-92, 2006.
14. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21:1779-86, 2003.
15. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 21:1011-53, 2003.
16. Blood Pressure Lowering Treatment Trialist’ Collaboration. Effects of ACE inhibitors, calcium channel blockers, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356:1955-64, 2000.
17. Marques E, Gil V, Casado JJ, Martel N, Figuera M, Martin JL, et al. Análisis de los estudios publicados sobre el incumplimiento terapéutico en el tratamiento de la hipertensión arterial en España entre los años 1984 y 2005. Aten Primaria 38:325-32, 2006.